Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 8.340M
March 31, 2026 8.340M
December 31, 2025 8.340M
September 30, 2025 6.317M
June 30, 2025 6.317M
March 31, 2025 6.317M
December 31, 2024 1.403M
September 30, 2024 1.115M
June 30, 2024 1.082M
March 31, 2024 1.043M
December 31, 2023 0.758M
September 30, 2023 0.5563M
June 30, 2023 0.5528M
March 31, 2023 0.5056M
Date Value
December 31, 2022 0.4828M
September 30, 2022 0.4641M
June 30, 2022 0.4641M
March 31, 2022 0.4641M
December 31, 2021 0.4641M
September 30, 2021 0.384M
June 30, 2021 0.384M
March 31, 2021 0.384M
December 31, 2020 0.324M
September 30, 2020 0.324M
June 30, 2020 0.384M
March 31, 2020 0.324M
December 31, 2019 0.324M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 266.16M
Cellectis SA 100.70M
Akari Therapeutics Plc 1.750M
DBV Technologies SA 59.18M
argenx SE --